| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
40,379,617 | 28,310,935 | 21,603,837 | 18,676,043 | 22,067,242 |
| Cost of Revenue
|
-15,718,062 | -10,886,103 | -8,857,861 | -7,918,828 | -10,710,148 |
|
Gross Profit
|
24,661,555 | 17,424,832 | 12,745,976 | 10,757,215 | 11,357,094 |
| Selling, General and Administrative Expenses
|
-6,701,472 | -5,738,349 | -5,018,577 | -4,313,213 | -4,393,548 |
|
Research and Development Expenses
|
-3,063,853 | -2,556,457 | -2,198,622 | -1,757,322 | -1,917,411 |
|
Operating Income/Expenses
|
-9,765,325 | -8,294,806 | -7,217,199 | -6,070,535 | -6,310,959 |
|
Total Operating Profit/Loss
|
14,896,230 | 9,130,026 | 5,528,777 | 4,686,680 | 5,046,135 |
| Total Net Finance Income/Expense
|
51,253 | 56,426 | 47,880 | 24,592 | -19,425 |
| Net Investment Income
|
1,901,804 | 1,303,782 | 974,442 | 410,427 | 1,217,560 |
| Irregular Income/Expenses
|
3,603,440 | 3,366,378 | -37,926 | -56,426 | 76,336 |
|
Other Income/Expense, Non-Operating
|
37,599 | 61,149 | 195,390 | 100,810 | 120,862 |
|
Non-Operating Income/Expenses, Total
|
5,594,096 | 4,787,735 | 1,179,786 | 479,403 | 1,395,333 |
|
Pretax Income
|
20,490,326 | 13,917,761 | 6,708,563 | 5,166,083 | 6,441,468 |
|
Provision for Income Tax
|
-3,549,898 | -1,991,862 | -1,308,450 | -1,070,409 | -1,219,910 |
|
Net Income from Continuing Operations
|
16,940,428 | 11,925,899 | 5,400,113 | 4,095,674 | 5,221,558 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
16,940,428 | 11,925,899 | 5,400,113 | 4,095,674 | 5,221,558 |
|
Non-Controlling/Minority Interests
|
-337,418 | -233,847 | -135,862 | -116,427 | -115,734 |
|
Net Income after Non-Controlling/Minority Interests
|
16,603,010 | 11,692,052 | 5,264,251 | 3,979,247 | 5,105,824 |
|
Net Income Available to Common Stockholders
|
16,603,010 | 11,692,052 | 5,264,251 | 3,979,247 | 5,105,824 |
|
Diluted Net Income Available to Common Stockholders
|
16,603,010 | 11,692,052 | 5,264,251 | 3,979,247 | 5,105,824 |
| Basic EPS
|
39.29 | 27.70 | 12.49 | 9.45 | 12.14 |
| Diluted EPS
|
39.08 | 27.51 | 12.38 | 9.37 | 12.00 |
|
Basic Weighted Average Shares Outstanding
|
422,605.95 | 422,095.74 | 421,477.26 | 421,084.34 | 420,578.58 |
|
Diluted Weighted Average Shares Outstanding
|
424,539.24 | 425,010.98 | 425,222.21 | 424,679.51 | 425,485.33 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
20,439,073 | 13,861,335 | 6,660,683 | 5,141,491 | 6,460,893 |
|
EBITDA
|
21,346,181 | 14,701,972 | 7,435,845 | 5,888,085 | 7,144,593 |
|
Normalized EBITDA
|
17,102,085 | 10,419,553 | 7,401,552 | 6,100,222 | 6,274,782 |
|
Normalized Income
|
13,431,613.14 | 8,256,366.96 | 5,372,508.58 | 4,263,856.43 | 4,516,475.29 |
|
Total Unusual Items
|
-4,244,096 | -4,282,419 | -34,293 | 212,137 | -869,811 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade